{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:22:15Z","timestamp":1774272135194,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00266","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T04:13:30Z","timestamp":1507004010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Associations between Systemic Sclerosis and Thyroid Diseases"],"prefix":"10.3389","volume":"8","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Ruffilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Colaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clodoveo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients\u2019 population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B2","first-page":"3","article-title":"One year in review 2016: a systemic sclerosis","volume":"34","author":"Barsotti","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","article-title":"Innate immunity in systemic sclerosis","volume":"19","author":"Dowson","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"Health-related quality of life in systemic sclerosis: a systematic review","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B9","first-page":"342","article-title":"[Scleroderma with traces of disseminated lupus erythematosus associated with Hashimoto\u2019s thyroiditis and papillary carcinoma of the thyroid gland (author\u2019s transl)]","volume":"73","author":"S\u00e1nchez de Rivera","year":"1979","journal-title":"Med Clin (Barc)"},{"key":"B10","first-page":"471","article-title":"[Gougerot-Sj\u00f6gren syndrome, connective tissue diseases and autoimmune pathology]","volume":"44","author":"Kaplan","year":"1977","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"B11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.7326\/0003-4819-95-4-431","article-title":"Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism","volume":"95","author":"Gordon","year":"1981","journal-title":"Ann Intern Med"},{"key":"B12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2340\/00015555663538","article-title":"Thyroid hormones in generalized scleroderma. A controlled study","volume":"66","author":"Serup","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"B13","first-page":"103","article-title":"Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma)","volume":"13","author":"Kahl","year":"1986","journal-title":"J Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF03349530","article-title":"Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis","volume":"13","author":"De Keyser","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2340\/0001555572112114","article-title":"Evaluation of thyroid function and anti-thyroid autoantibodies in systemic sclerosis","volume":"72","author":"Moln\u00e1r","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"B16","first-page":"529","article-title":"Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase (anti-TPO) antibodies with HLA-DR15","volume":"15","author":"Molteni","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00393-002-0413-7","article-title":"Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity","volume":"61","author":"Shahin","year":"2002","journal-title":"Z Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s10067-003-0803-5","article-title":"High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome","volume":"22","author":"Innocencio","year":"2003","journal-title":"Clin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10067-005-1165-y","article-title":"Association of systemic and thyroid autoimmune diseases","volume":"25","author":"Bir\u00f3","year":"2006","journal-title":"Clin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-06-0591","article-title":"Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis","volume":"156","author":"Antonelli","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1196\/annals.1422.032","article-title":"Thyroid dysfunction in women with systemic sclerosis","volume":"1108","author":"Marasini","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaut.2008.05.002","article-title":"Polyautoimmunity and familial autoimmunity in systemic sclerosis","volume":"31","author":"Hudson","year":"2008","journal-title":"J Autoimmun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03009742.2010.549837","article-title":"Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma","volume":"40","author":"Danielides","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/1346-8138.12698","article-title":"Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis","volume":"41","author":"Toki","year":"2014","journal-title":"J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E1198","DOI":"10.1210\/jc.2012-3583","article-title":"Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up","volume":"98","author":"Antonelli","year":"2013","journal-title":"Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10067-016-3209-x","article-title":"Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India","volume":"35","author":"Singh","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.20452\/pamw.3583","article-title":"Presence of organ-specific antibodies in patients with systemic sclerosis","volume":"126","author":"Wielosz","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"B28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10067-016-3535-z","article-title":"Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature","volume":"36","author":"Giuggioli","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis \u2013 a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","article-title":"Evidence for the involvement of type I interferon in pulmonary arterial hypertension","volume":"114","author":"George","year":"2014","journal-title":"Circ Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E413","DOI":"10.1210\/jc.2010-0923","article-title":"CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves\u2019 and normal thyrocytes","volume":"95","author":"Antonelli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fendo.2017.00138","article-title":"Systemic lupus erythematosus and thyroid autoimmunity","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol"},{"key":"B36","first-page":"1809","article-title":"Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis","volume":"35","author":"Antonelli","year":"2008","journal-title":"J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1001\/archinte.1986.00360240064012","article-title":"Progressive systemic sclerosis and Graves\u2019 disease. Report of three cases","volume":"146","author":"Nicholson","year":"1986","journal-title":"Arch Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3109\/01676830903104637","article-title":"Graves\u2019 disease associated with primary systemic sclerosis","volume":"28","author":"Wimmersberger","year":"2009","journal-title":"Orbit"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-016-3288-8","article-title":"Risk factors for malignancy in systemic sclerosis patients","volume":"35","author":"Ka\u015fifo\u011flu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.12659\/AJCR.894176","article-title":"Mixed connective tissue disease and papillary thyroid cancer: a case report","volume":"16","author":"Thongpooswan","year":"2015","journal-title":"Am J Case Rep"},{"key":"B41","first-page":"24","article-title":"Exacerbated course of atrophoderma of Pasini and Pierini in patient with papillary cancer of the thyroid gland","volume":"63","author":"Kope\u0107-Medrek","year":"2010","journal-title":"Wiad Lek"},{"key":"B42","first-page":"188","article-title":"Scleroderma with cardiac tamponade, hyperthyroidism and incidental papillary thyroid carcinoma","volume":"51","author":"Gokula","year":"2002","journal-title":"West Indian Med J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/rheumatology\/kev358","article-title":"Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis","volume":"55","author":"Antonelli","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.amjmed.2004.09.020","article-title":"Thyroid function, pulmonary arterial hypertension and scleroderma","volume":"118","author":"Marasini","year":"2005","journal-title":"Am J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:53:43Z","timestamp":1719492823000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":44,"alternative-id":["10.3389\/fendo.2017.00266"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00266","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]},"article-number":"266"}}